Evaluation of Cataract Surgery Outcome
Launched by EVIDENCE BASED CATARACT STUDY GROUP · Jul 7, 2014
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes of cataract surgery in patients with cataracts and high myopia (a condition where distant objects appear blurry). The main goal is to see how well participants can see after the surgery, including both their best vision without glasses and with glasses, as well as other measurements related to their vision.
To be eligible for this study, participants need to have a clinical diagnosis of cataracts and should be able to cooperate during eye exams. Unfortunately, individuals with a clinical diagnosis of mental illness or those who are mentally disabled cannot participate. If you decide to join the trial, you can expect to undergo various eye tests before and after your cataract surgery to help researchers understand the surgery's effectiveness. The trial is currently looking for participants of all ages, so if you or a loved one fit the criteria, this could be a valuable opportunity to contribute to important research in eye health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of cataract
- • Must be able to cooperate with the ophthalmic examination
- Exclusion Criteria:
- • Clinical diagnosis of mental illness
- • Mentally disabled
About Evidence Based Cataract Study Group
The Evidence-Based Cataract Study Group is a dedicated clinical trial sponsor focused on advancing the understanding and treatment of cataracts through rigorous research. Committed to improving patient outcomes, the group conducts comprehensive studies that integrate evidence-based methodologies to evaluate the efficacy and safety of various cataract interventions. By fostering collaboration among leading ophthalmologists and researchers, the Evidence-Based Cataract Study Group aims to generate high-quality data that informs clinical practice and enhances the quality of care for individuals affected by cataracts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Yi Lu, MD
Study Chair
Eye and ENT Hospital of Fudan University
Xiangjia Zhu, MD
Study Director
Eye and ENT Hospital of Fudan University
Jin Yang, MD
Study Director
Eye and ENT Hospital of Fudan University
Keke Zhang, MD
Principal Investigator
Eye and ENT Hospital of Fudan University
Wenwen He, MD
Principal Investigator
Eye and ENT Hospital of Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials